The extract successfully restored the blood glucose levels, body weight, and normalized oxidative stress on renal function in a test group of Zucker diabetic fatty rats.
14-Jun-2019 11:05 AM EDT Add to Favorites
RB1 status has emerged not only as a key factor in cancer development and progression, but also as a crucial determinant of cell fate in response to various anticancer treatments
11-Jun-2019 4:10 PM EDT Add to Favorites
Cervical Cancer During Pregnancy, Though Serious, is Highly Treatable According to New Research Review
“Individualized therapies are strongly recommended and the treatment decision should be made collaboratively with a multidisciplinary team consisting of obstetricians, gynecologists, oncologists, pediatricians, and psychologists,” says...
4-Jun-2019 9:55 AM EDT Add to Favorites
Drug reactivates p53 tumor suppressor protein and increases chemotherapy effectiveness in potential glioblastoma breakthrough.
20-May-2019 4:05 AM EDT Add to Favorites
Enzyme Inhibition May Lead to New Melanoma Therapy, Say Researchers at Fox Chase with Support from Sbarro Institute
Inhibition of the cellular enzyme thymine DNA glycosylase (TDG) may be an effective treatment for melanoma, according to research published in the journal Oncogene in January. The paper, “Thymine DNA glycosylase as a novel target for melanoma,”...
10-Apr-2019 12:05 PM EDT Add to Favorites
A synthetic DNA structure was used as bait to capture nuclear proteins, revealing previously unknown role of HNRNPD in the cellular response to DNA damage.
14-Mar-2019 9:00 AM EDT Add to Favorites
Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist.
4-Feb-2019 11:45 AM EST Add to Favorites
A study finds that palbociclib, in combination with endocrine therapy, improves progression free survival
11-Dec-2018 7:55 AM EST Add to Favorites
see all news
6-Jun-2018 11:35 AM EDT
16-Jan-2018 11:05 AM EST
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST